U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607873) titled 'TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal ... Read More
U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607405) titled 'Acute Effects of Instrument-Assisted Soft Tissue Mobilization Added to Postural Corrective E... Read More
Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More
Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More
U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607756) titled 'OCT-A Biomarkers for Cognitive Impairment in Patients With Chronic Atrial Fibrillation' on M... Read More
Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607561) titled 'Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjec... Read More
Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More
Singapore, May 27 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More